505PApatinib plus docetaxel as second-line treatment in patients with advanced non-small cell lung cancer (NSCLC) (NCT02780778). (25th November 2018) - Pan, Z; Wang, C; Xie, G; Liu, D; Yan, Z; Li, Y; Jiang, Z; Wang, B; Li, L